AN2 Therapeutics

ANTX52

Penny Stock

$1.34arrow_drop_up9.34%$0.11

Penny Stock

ANTX52

$1.34

arrow_drop_up9.34%$0.11

Penny Stock

Performance History

Key Stats
Open	$1.26
Prev. Close	$1.23
EPS	-1.99
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$40.03M
PE Ratio	-

	LOW	HIGH
Day Range	1.25	1.41
52 Week Range	0.87	22.22

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-1.99

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About AN2 Therapeutics (ANTX)

AN2 Therapeutics, Inc. (ANTX) is a biotechnology company focused on developing revolutionary treatments for neurological diseases. With a mission to improve the lives of patients suffering from conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, AN2 Therapeutics is at the forefront of innovation in the field of neurology.

The company's stock price history has shown steady growth since its initial public offering. ANTX has consistently outperformed the broader market, thanks to its groundbreaking research and development efforts. Investors have recognized the potential of AN2 Therapeutics' pipeline, resulting in a strong demand for the company's shares.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Eric E. Easom
Headquarters: Menlo Park
Employees: 35
Exchange: NASDAQ

Keep an eye on AN2 Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is AN2 Therapeutics's (ANTX) price per share?

The current price per share for AN2 Therapeutics (ANTX) is $1.34. The stock has seen a price change of $0.11 recently, indicating a 9.35% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for AN2 Therapeutics (ANTX)?

For AN2 Therapeutics (ANTX), the 52-week high is $22.22, which is 1.56K% from the current price. The 52-week low is $0.87, the current price is 54.02% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is AN2 Therapeutics (ANTX) a growth stock?

AN2 Therapeutics (ANTX) has shown an average price growth of -4.13% over the past three years. It has received a score of 25 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying AN2 Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is AN2 Therapeutics (ANTX) stock price performance year to date (YTD)?

As of the latest data, AN2 Therapeutics (ANTX) has a year-to-date price change of -93.26%. Over the past month, the stock has experienced a price change of 24.07%. Over the last three months, the change has been 20.72%. Over the past six months, the figure is -36.79%.

help

Is AN2 Therapeutics (ANTX) a profitable company?

AN2 Therapeutics (ANTX) has a net income of -$64.73M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$69.64M. Furthermore, the EBITDA is $0.

help

What is the market capitalization of AN2 Therapeutics (ANTX)?

AN2 Therapeutics (ANTX) has a market capitalization of $40.04M. The average daily trading volume is 1.35, indicating the stock's liquidity and investor engagement.